This overexpression is also prevalent in various cancers that exhibit chemotherapy resistance, where RRM2's upregulation activates complex signaling pathways that regulate survival, growth, apoptosis, and chemoresistance in cancer cells. This evidence concerns the gene RRM2 and cancer.